FdaApplication
BLA 761399
Identifiers
- fda_app_no: BLA761399
Properties
| Property | Value |
|---|---|
| applicant_name | CELLTRION, Inc. |
| application_type | BLA |
| approval_date | 2025-03-07 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OMLYCLO | OMALIZUMAB-IGEC | 75MG/0.5ML | Injection |
| OMLYCLO | OMALIZUMAB-IGEC | 300MG/2ML (150MG/ML) | Injection |
| OMLYCLO | OMALIZUMAB-IGEC | 150MG/ML | Injection |
3 products